STARHEALTH Share Price Target 2035

CAGR-based price projection for Star Health and Allied Insurance Company Limited (STARHEALTH) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (5.8% CAGR)
Rs 894
2035 Target
Base Case (14.5% CAGR)
Rs 1,824
2035 Target
Bull Case (40.5% CAGR)
Rs 11,506
2035 Target

Current Market Snapshot

CMP: Rs 537.70
52W High: Rs 610.40
52W Low: Rs 469.45
1Y CAGR: 31.2%
3Y CAGR: 14.5%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 569 Rs 616 Rs 756
2028 Rs 602 Rs 705 Rs 1,062
2029 Rs 637 Rs 808 Rs 1,493
2030 Rs 674 Rs 925 Rs 2,098
2031 Rs 713 Rs 1,060 Rs 2,949
2032 Rs 755 Rs 1,214 Rs 4,145
2033 Rs 799 Rs 1,391 Rs 5,825
2034 Rs 845 Rs 1,593 Rs 8,187
2035 Rs 894 Rs 1,824 Rs 11,506

Other STARHEALTH Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the STARHEALTH share price target for 2035?

Based on historical growth analysis, the STARHEALTH share price target for 2035 ranges from Rs 894 (conservative) to Rs 1,824 (base case) to Rs 11,506 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of STARHEALTH?

The current market price of STARHEALTH (Star Health and Allied Insurance Company Limited) is Rs 537.70. The 52-week high is Rs 610.40 and 52-week low is Rs 469.45.

Is STARHEALTH a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for STARHEALTH price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 5.8% CAGR), Base (14.5% CAGR), and Bull (optimistic at 40.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.